Business Wire

Ondo Finance and Alpaca Collaborate to Tokenize US Stocks and ETFs

Share

Bridging traditional finance and on-chain markets, increasing access to high-quality assets

Today, Ondo Finance, a leader in blockchain-based financial innovation and tokenized real-world assets, announced the launch of Ondo Global Markets, their platform for tokenized US stocks and ETFs. The platform is powered by a strategic integration with Alpaca, a self-clearing broker-dealer and brokerage infrastructure API for stocks, ETFs, and options trading, as well as crypto.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903244835/en/

Ondo Finance and Alpaca collaborate to tokenize US stocks and ETFs; bridging traditional finance and on-chain markets, increasing access to high-quality assets.

According to a McKinsey report, the tokenized market capitalization could reach around $2 trillion by 2030 across a variety of asset classes. This expected rise in market demand for tokenized assets, like US stocks and ETFs, comes as global investors continue to face barriers, including strict market access rules, high minimums, and cumbersome settlement processes. The collaboration between Ondo and Alpaca aims to remove these barriers.

Powered by Alpaca’s Broker API, Ondo Global Markets is offering:

  • 100+ Assets Live, 1,000+ Coming – Leading tokenized stocks and ETFs are now available, with plans to scale to 1,000+ by year-end
  • Transferable 24/7 – Tokenized stocks and ETFs are transferable peer-to-peer and available 24/7/365 where allowed
  • Deep Liquidity – Global Markets provides access similar to traditional exchange liquidity for on-chain investors
  • Usable in DeFi – Ondo assets behave like stablecoins for ease of use and automation, enabling tokenized stocks to be used in DeFi
  • Industry Backing – Ondo tokenized stocks are fully backed by US stocks and ETFs which are held in custody by US broker-dealers and independent security agents

Available now across qualified Asia-Pacific, African, and Latin American markets, Ondo Global Markets is providing access to over 100 tokenized US stocks and ETFs, with plans to increase to over 1,000 assets available by the end of the year.

“Global investors have historically faced barriers to accessing the approximately $63 trillion US securities markets due to high fees, limited access, transfer frictions, platform fragmentation, and geographic exclusions, locking millions out of capital markets,” says Ian De Bode, Chief Strategy Officer at Ondo Finance. “Working with Alpaca allows us to tokenize US stocks and ETFs with the speed, accessibility, and programmability of blockchain for these global investors.”

"The future of finance lies in bridging traditional and decentralized markets," says Yoshi Yokokawa, CEO and Co-Founder of Alpaca. "Ondo reflects that, and Alpaca is dedicated to enabling this transformation globally with the infrastructure that makes it possible."

This collaboration highlights the ongoing evolution of the financial landscape, where technology may make certain investment opportunities more globally accessible. Ondo Global Markets is currently available on Ethereum, with Solana and BNB Chain launching soon.

About Alpaca

Alpaca is a US-headquartered self-clearing broker-dealer and brokerage infrastructure for stocks, ETFs, fixed income, 24/5, options trading, and offers crypto–raising over USD170 million in funding. Alpaca is backed by top-tier investors globally, including Portage Ventures, Spark Capital, Tribe Capital, Social Leverage, Horizons Ventures, Unbound, SBI Group, Derayah Financial, Elefund, and Y Combinator. For more information, visit: alpaca.markets

About Ondo Finance

Ondo is a blockchain technology company. Its mission is to accelerate the transition to an open economy by building the platforms, assets, and infrastructure that bring financial markets on-chain. For more information, visit ondo.finance

Please read Characteristics and Risks of Standardized Options before investing in options.

All investments involve risk; for more information, please see our Disclosure Library. Cryptocurrency is highly speculative, volatile, and may result in total loss of value. Please click here for more information.

Tokenization services are not available in all jurisdictions. Alpaca Crypto LLC provides digital asset services, while securities underlying tokenized assets are custodied by Alpaca Securities LLC. Neither entity is the issuer of, or involved in, the tokenization of any assets. Tokenized assets are issued by third parties, do not represent direct equity ownership, and carry unique risks. Please review the Tokenization Disclosure for risk information.

Alpaca Securities LLC (member FINRA/SIPC) and Alpaca Crypto LLC (NMLS# 2160858 a FinCEN-registered MSB, not a member of FINRA/SIPC) are wholly owned subsidiaries of AlpacaDB, Inc.; cryptocurrencies carry unique risks and are not FDIC- or SIPC-protected. This is not an offer or solicitation to buy or sell securities or cryptocurrencies, or to open an account, in any jurisdiction where Alpaca is unregistered or unlicensed.

Alpaca and Ondo Finance are not affiliated; neither party is responsible for the liabilities of the other.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250903244835/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OpZira, Inc. Launches to Advance Ophthalmic Diagnostics with Innovative Medical Device Portfolio3.9.2025 19:23:00 CEST | Press release

OpZira™, Inc., a forward-thinking ophthalmic medical device company founded on a legacy of research excellence, today announced its official formation. OpZira is dedicated to delivering innovative technologies that enhance the detection and monitoring of ocular disease, empowering clinicians with advanced diagnostic tools. OpZira’s creation follows Alcon’s acquisition of LumiThera (https://www.alcon.com/media-release/alcon-completes-acquisition-lumithera/) and its innovative Valeda® Light Delivery System, the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD). As part of the transaction, LumiThera’s diagnostic product lines were spun off to LumiThera shareholders, leading to the establishment of OpZira, Inc. OpZira’s product portfolio includes: AdaptDx Pro® – A wearable dark adaptometer that leverages AI to ensure a consistent patient experience. Impaired dark adaptation speed, a key early indicator of rod-mediated dysfunction, is often among the fir

​BTG Bioliquids and NanosTech Partner to Deliver End-to-End Advanced Biofuels Solution3.9.2025 18:19:00 CEST | Press release

BTG Bioliquids BV (BTL), a Netherlands-based leader in fast pyrolysis technology, and NanosTech Technology & Innovations Ltd. (NanosTech), a Canada-based catalyst development and manufacturing company, have signed a Memorandum of Understanding (MOU) to deliver a fully integrated solution to produce advanced, drop-in biofuels. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903698730/en/ The partnership combines BTL’s proven fast pyrolysis technology, which converts sustainable biomass into bio-oil, with NanosTech’s proprietary Aquaprocessing (AQP) platform, which upgrades even the most challenging bio-oils into refinery-ready feedstocks to produce fuels such as sustainable aviation fuel (SAF), renewable diesel, and marine fuels. The two companies are now actively collaborating to determine the location in Canada and Europe for the new 500-barrel-per-day modular biorefinery system. This system can be deployed near the feeds

Armis Named a Leader in IoT Security Solutions, Q3 2025 Evaluation3.9.2025 15:58:00 CEST | Press release

Recognition follows Armis being named a Leader in Unified Vulnerability Management Solutions evaluation Armis, the cyber exposure management & security company, today announced that it has been named a Leader in The Forrester Wave™: IoT Security Solutions, Q3 2025. This achievement comes on the heels of Armis being named a Leader in The Forrester Wave™: Unified Vulnerability Management Solutions, Q3 2025. In this Forrester Wave™, Armis is ranked a Leader and achieved the highest scores possible in 9 key criteria. According to the report, “Armis’ vision centers on delivering enterprise-wide exposure management that goes beyond IoT and OT devices. Its innovation investments and acquisitions support this goal. Its roadmap aligns with customer priorities while anticipating future needs to ensure the platform evolves alongside its clients. This forward-looking strategy fosters successful adoption and helps customers deploy the Centrix platform successfully.” “We’re proud to once again be re

Rapid Medical™ Surpasses 1,000 Cases With DRIVEWIRE™ 24 in North America and Expands Into Europe With MDR Approval3.9.2025 15:46:00 CEST | Press release

Clinical performance and strong physician demand drive swift uptake and global approval of next-generation access technology Rapid Medical™, a leading developer of active endovascular devices, announces that its DRIVEWIRE™ 24 steerable guidewire has been used in more than 1,000 neurovascular procedures in North America during a limited commercial launch beginning earlier this year. The company also announced receipt of CE Mark under the European Medical Device Regulation (MDR), as presented at the 2025 ESMINT Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250903530140/en/ “In my experience, the wire provides a unique combination of precision and support that simply hasn’t been possible with conventional technologies,” stated Dr. Erez Nossek, a neurosurgeon at NYU Langone in New York, NY. “It has become a reliable tool that allows us to approach any anatomy with greater efficiency and less time.” As the first

TON Strategy Company Approves $250 Million Stock Repurchase Program After Ticker Change3.9.2025 15:20:00 CEST | Press release

Open-ended stock repurchase program unanimously approved by the board Aims to create shareholder value by growing Net Asset Value per Share (NAV/share), including in times of heightened volatility TON Strategy Company (formerly Verb Technology Company Inc.) (Nasdaq: TONX) (the “Company”), a digital asset treasury company committed to holding Toncoin ($TON), today announced that its Board of Directors has unanimously approved a stock repurchase program authorizing the Company to repurchase up to $250 million of its common stock. Under the program, repurchases may be made from time to time in open market transactions or through other means in accordance with applicable securities laws. The timing, number of shares of common stock repurchased, and price will depend on a variety of factors including liquidity, market conditions, share price, and other considerations. The program does not obligate the Company to acquire any specific number of shares of the Company’s common stock. "We are co

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye